It was designed with a fatty acid chain that allows it to bind to albumin, dramatically slowing its breakdown in the body
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
It's absolute
These actions lower blood glucose levels, which contributes to weight loss and improved blood sugar control
and international guidelines are rapidly evolving to address the risks associated with GLP-1 use
The company already offers access to branded GLP-1 medications such a Ozempic, Zepbound, Wegovy and Mounjaro